Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
February 16, 2011
Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone
Jong Yeon Hwang, Wenwei Huang, Leggy A Arnold, et al.
European Journal of Medicinal Chemistry
|
September 22, 2020
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
Akshay D Takwale, Seung-Hyun Jo, Yeong Uk Jeon, et al.
Archives of Pharmacal Research
|
January 13, 2016
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
Eun-Young Kim, Seung-Tae Kang, Heejung Jung, et al.
European Journal of Medicinal Chemistry
|
April 19, 2025
Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder
Seulki Park, Akshay D Takwale, Ji-Eun Lee, et al.
Cancers
|
September 10, 2020
Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in <i>EZH2</i> Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
Sungryul Park, Seung-Hyun Jo, Jong-Hwan Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2015
Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitor
Ga Ae Kang, Minji Lee, Dawn Song, et al.
European Journal of Medicinal Chemistry
|
November 2, 2013
Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors
Jong Yeon Hwang, Hee-Young Kim, Suyeon Jo, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2014
Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors
Seung-Tae Kang, Eun-Young Kim, Raghavendra Achary, et al.
Scientific Reports
|
December 25, 2019
Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
Kidae Kim, Dong Ho Lee, Sungryul Park, et al.
Cancer Letters
|
March 1, 2016
Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer
Chung Hyo Kang, Eun-Young Kim, Hyoung Rae Kim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
February 16, 2011
Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone
Jong Yeon Hwang, Wenwei Huang, Leggy A Arnold, et al.
European Journal of Medicinal Chemistry
|
September 22, 2020
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
Akshay D Takwale, Seung-Hyun Jo, Yeong Uk Jeon, et al.
Archives of Pharmacal Research
|
January 13, 2016
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
Eun-Young Kim, Seung-Tae Kang, Heejung Jung, et al.
European Journal of Medicinal Chemistry
|
April 19, 2025
Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder
Seulki Park, Akshay D Takwale, Ji-Eun Lee, et al.
Cancers
|
September 10, 2020
Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in <i>EZH2</i> Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
Sungryul Park, Seung-Hyun Jo, Jong-Hwan Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2015
Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitor
Ga Ae Kang, Minji Lee, Dawn Song, et al.
European Journal of Medicinal Chemistry
|
November 2, 2013
Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors
Jong Yeon Hwang, Hee-Young Kim, Suyeon Jo, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 2014
Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors
Seung-Tae Kang, Eun-Young Kim, Raghavendra Achary, et al.
Scientific Reports
|
December 25, 2019
Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
Kidae Kim, Dong Ho Lee, Sungryul Park, et al.
Cancer Letters
|
March 1, 2016
Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer
Chung Hyo Kang, Eun-Young Kim, Hyoung Rae Kim, et al.
Page
of 6